DECAV protocol
(LNYFDDGDGBFMNK-BDJZTNMDSA-L)
Structure
- SMILES
- CN(/N=N/c1nc[nH]c1C(=O)N)C.OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](N)[C@@H]([C@@H](O2)C)O)c2c(C1)c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2OC.COC(=O)[C@@H]1[C@H]([C@@H]2CN(CCC3C1Nc1c3cccc1)C[C@](C2)(O)CC)c1cc2c(cc1OC)N([C@@H]1[C@@]32CCN2[C@H]3[C@@](CC)(C=CC2)[C@H]([C@]1(O)C(=O)N)O)C.ClCCN(P1(=O)NCCCO1)CCCl.Cl[Pt+2]Cl.[NH2-].[NH2-]
- Molecular Formula:
- C83H115Cl4N16O21PPt
- Molecular Weight:
- 2040.760
- Log P:
- 9.9736
- Hydrogen Bond Acceptor:
- 34
- Hydrogen Bond Donor:
- 16
- TPSA:
- 570.28
- CAS Number(s):
- N/A
Synonym(s)
1.
DECAV protocol
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Uterine Neoplasms | 12445254 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120289
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.